Pregnancy outcomes in familial hypercholesterolemia: A registry-based study

Circulation

Volumn 124, Issue 15, 2011, Pages 1606-1614

  Toleikyte, Ieva ^a   Retterstøl, Kjetil ^b   Leren, Trond Paul ^c   Iversen, Per Ole ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b Lipid Clinic   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

atherosclerosis; hypercholesterolemia, familial; myocardial infarction; pregnancy; registries

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CONGENITAL MALFORMATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOTE; HIGH RISK PREGNANCY; HUMAN; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION; PREGNANCY OUTCOME; PREMATURITY; PRIORITY JOURNAL; RECEPTOR GENE; REGISTER; RISK ASSESSMENT;

ADOLESCENT; ADULT; BIRTH WEIGHT; CONGENITAL ABNORMALITIES; FEMALE; HETEROZYGOTE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; INCIDENCE; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MIDDLE AGED; MUTATION; NORWAY; ODDS RATIO; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREMATURE BIRTH; RECEPTORS, LDL; REGISTRIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 80053984968     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.990929     Document Type: Article

References (34)

1. Goldstein JL, Brown MS. Familial hypercholesterolemia: pathogenesis of a receptor disease. Johns Hopkins Med J. 1978;143:8-16. (Pubitemid 9002144)
2. Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J. 2008;29: 2625-2633.
3. Civeira F. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55-68. (Pubitemid 38224196)
4. Rees A. Familial hypercholesterolaemia: underdiagnosed and undertreated. Eur Heart J. 2008;29:2583-2584.
5. Heiberg A, Berg K. The inheritance of hyperlipoproteinaemia with xanthomatosis: a study of 132 kindreds. Clin Genet. 1976;9:203-233.
6. Herrera E, Amusquivar E, Lopez-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res. 2006;65(suppl 3): 59-64. (Pubitemid 44689434)
7. Martin U, Davies C, Hayavi S, Hartland A, Dunne F. Is normal pregnancy atherogenic? Clin Sci. 1999;96:421-425. (Pubitemid 29179150)
8. Amundsen AL, Khoury J, Iversen PO, Bergei C, Ose L, Tonstad S, Retterstøl K. Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia. Atherosclerosis. 2006;189:451-457. (Pubitemid 44740297)
9. Robertson WB, Brosens I, Dixon G. Maternal uterine vascular lesions in the hypertensive complications of pregnancy. Perspect Nephrol Hypertens. 1976;5:115-127.
10. Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, Roberts JM. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007;197:610-617.
11. Langsted A, Freiberg JJ, Nordestgaard BG. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction. Circulation. 2008;118: 2047-2056.
12. Wilcox A, Russell I. Why small black infants have a lower mortality rate than small white infants: the case for population-specific standards for birth weight. J Pediatr. 1990;116:7-10. (Pubitemid 20038254)
13. Wilcox AJ, Russell IT. Birthweight and perinatal mortality: III. Towards a new method of analysis. Int J Epidemiol. 1986;15:188-196. (Pubitemid 16001818)
14. Wilcox AJ, Skjærven R. Birth weight and perinatal mortality: the effect of gestational age. Am J Public Health. 1992;82:378-382.
15. Skjærven R, Gjessing HK, Bakketeig LS. Birthweight by gestational age in Norway. Acta Obstet Gynecol Scand. 2000;79:440-449. (Pubitemid 30326124)
16. EUROCAT Report 7: 15 years of surveillance of congenital anomalies in Europe 1980-1994. Brussels; 1997.
17. Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO. Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia. Thromb Res. 2007;120:21-27. (Pubitemid 46628704)
18. Hameed AB, Tummala PP, Goodwin TM, Nuno I, Wani OR, Karaalp IS, Elkamya U. Unstable angina during pregnancy in two patients with premature coronary atherosclerosis and aortic stenosis in association with familial hypercholesterolemia. Am J Obstet Gynecol. 2000;182:1152-1155. (Pubitemid 30353304)
19. Mousa HA, McKinley CA, Thong J. Acute postpartum myocardial infarction after ergometrine administration in a woman with familial hypercholesterolaemia. BJOG. 2000;107:939-940. (Pubitemid 30417354)
20. Makino H, Harada-Shiba M. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia. Ther Apher Dial. 2003;7:397-401. (Pubitemid 37082026)
21. Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO. Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia. Acta Obstet Gynecol Scand. 2008;29:1-5.
22. Edison RJ, Berg K, Remaley A, Kelley R, Rotimi C, Stevenson RE, Muenke M. Adverse birth outcome among mothers with low serum cholesterol. Pediatrics. 2007;120:723-733. (Pubitemid 47549559)
23. Khoury J, Henriksen T, Christophersen B, Tonstad S. Effect of a cholesterollowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomized clinical trial. Am J Obstet Gynecol. 2005;193:1292-1301. (Pubitemid 41395095)
24. Khoury J, Haugen G, Tonstad S, Froslie KF, Henriksen T. Effect of a cholesterol-lowering diet during pregnancy on maternal and fetal Doppler velocimetry: the CARRDIP study. Am J Obstet Gynecol. 2007;196: 549-557.
25. Basso O, Rasmussen S, Weinberg CR, Wilcox AJ, Irgens LM, Skjærven R. Trends in fetal and infant survival following preeclampsia. JAMA. 2006;296:1357-1362. (Pubitemid 44427421)
26. Belogolovkin V, Alio AP, Mbah AK, Clayton HB, Wathington D, Salihu HM. Patterns and success of fetal programming among women with low and extremely low pre-pregnancy BMI. Arch Gynecol Obstet. 2009;280: 579-584.
27. Ehrenberg HM, Dierker L, Milluzzi C, Mercer BM. Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes. Am J Obstet Gynecol. 2003;189:1726-1730. (Pubitemid 38056451)
28. Bhattacharya S, Campbell DM, Liston WA, Bhattacharya S. Effect of body mass index on pregnancy outcomes in nulliparous women delivering singleton babies. BMC Public Health. 2007;7:168-175.
29. Alam DS. Prevention of low birthweight. Nestle Nutr Workshop Ser Pediatr Program. 2009;63:209-221.
30. Dougherty CR, Jones AD. The determinants of birth weight. Am J Obstet Gynecol. 1982;144:190-200. (Pubitemid 12068876)
31. Wikstrom I, Axelsson O, Bergstrom R. Maternal factors associated with high birth weight. Acta Obstet Gynecol Scand. 1991;70:55-61.
32. Lunde A, Melve KK, Gjessing HK, Skjærven R, Irgens LM. Genetic and environmental influences on birth weight, birth length, head circumference, and gestational age by use of population-based parent-offspring data. Am J Epidemiol. 2007;165:734-741. (Pubitemid 46434610)
33. Leren TP, Solberg K, Rodningen OK, Tonstad S, Ose L. Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects. Atherosclerosis. 1994;111:175-182. (Pubitemid 24382544)
34. Sundvold H, Solberg K, Tonstad S, Rødningen OK, Ose L, Berg K, Leren TP. A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects. Hum Mutat. 1996;7:70-71. (Pubitemid 26002091)